Resectable MMR-deficient Solid Tumors
1 clinical trials · Condition
◉ Watch Resectable MMR-deficient Solid Tumors
| Record | Firm | Date |
|---|---|---|
| Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (NCT06279130) | The Netherlands Cancer Institute | 2024-01-29 |
Track Resectable MMR-deficient Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.